TEST BANK
b
,TEST BANK FOR
b b
Pharmacology and the Nursing Process 8th Edition
b b b b b b
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
b b b b b b b b
Contents
Chapter 01: The Nursing Process and Drug Therapy....................................................................................... 4
b b b b b b b
Chapter 02: Pharmacologic Principles ............................................................................................................ 8
b b b
Chapter 03: Lifespan Considerations............................................................................................................ 14
b b b
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................... 20
b b b b b b
Chapter 05: Medication Errors: Preventing and Responding........................................................................ 26
b b b b b b
Chapter 06: Patient Education and Drug Therapy ........................................................................................ 29
b b b b b b
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ................................................ 34
b b b b b b b b
Chapter 08: Gene Therapy and Pharmacogenomics .................................................................................... 38
b b b b b
Chapter 09: Photo Atlas of Drug Administration .......................................................................................... 41
b b b b b b
Chapter 10: Analgesic Drugs......................................................................................................................... 50
b b b
Chapter 11: General and Local Anesthetics.................................................................................................. 57
b b b b b
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................... 61
b b b b b b b b
Chapter 13: Central Nervous System Stimulants and Related Drugs ............................................................ 66
b b b b b b b b
Chapter 14: Antiepileptic Drugs ................................................................................................................... 70
b b b
Chapter 15: Antiparkinson Drugs ................................................................................................................. 76
b b b
Chapter 16: Psychotherapeutic Drugs .......................................................................................................... 81
b b b
Chapter 17: Substance Abuse ...................................................................................................................... 88
b b b
Chapter 18: Adrenergic Drugs ...................................................................................................................... 93
b b b
Chapter 19: Adrenergic-Blocking Drugs ....................................................................................................... 98
b b b
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
b b b
Chapter 21: Cholinergic-Blocking Drugs ..................................................................................................... 108
b b b
Chapter 22: Antihypertensive Drugs .......................................................................................................... 113
b b b
Chapter 23: Antianginal Drugs ................................................................................................................... 119
b b b
Chapter 24: Heart Failure Drugs ................................................................................................................. 125
b b b b
Chapter 25: Antidysrhythmic Drugs ........................................................................................................... 131
b b b
Chapter 26: Coagulation Modifier Drugs .................................................................................................... 137
b b b b
Chapter 27: Antilipemic Drugs ................................................................................................................... 143
b b b
,Chapter 28: Diuretic Drugs ......................................................................................................................... 148
b b b
Chapter 29: Fluids and Electrolytes ............................................................................................................ 154
b b b b
Chapter 30: Pituitary Drugs ........................................................................................................................ 160
b b b
Chapter 31: Thyroid and Antithyroid Drugs................................................................................................ 163
b b b b b
Chapter 32: Antidiabetic Drugs .................................................................................................................. 168
b b b
Chapter 33: Adrenal Drugs ......................................................................................................................... 177
b b b
Chapter 34: Women’s Health Drugs ........................................................................................................... 181
b b b b
Chapter 35: Men’s Health Drugs ................................................................................................................ 188
b b b b
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ............................................ 193
b b b b b b
Chapter 37: Respiratory Drugs ................................................................................................................... 198
b b b
Chapter 38: Antibiotics Part 1..................................................................................................................... 204
b b b b
Chapter 39: Antibiotics Part 2..................................................................................................................... 211
b b b b
Chapter 40: Antiviral Drugs ........................................................................................................................ 216
b b b
Chapter 41: Antitubercular Drugs .............................................................................................................. 221
b b b
Chapter 42: Antifungal Drugs ..................................................................................................................... 226
b b b
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................. 231
b b b b b b
Chapter 44: Anti-inflammatory and Antigout Drugs................................................................................... 236
b b b b b
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs.......................... 242
b b b b b b b b b b b
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ............. 248
b b b b b b b b b b b
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ........................................................ 253
b b b b b b
Chapter 48: Immunosuppressant Drugs .................................................................................................... 258
b b b
Chapter 49: Immunizing Drugs ................................................................................................................... 263
b b b
Chapter 50: Acid-Controlling Drugs............................................................................................................ 268
b b b
Chapter 51: Bowel Disorder Drugs ............................................................................................................. 274
b b b b
Chapter 52: Antiemetic and Antinausea Drugs .......................................................................................... 281
b b b b b
Chapter 53: Vitamins and Minerals ............................................................................................................ 286
b b b b
Chapter 54: Anemia Drugs ......................................................................................................................... 292
b b b
Chapter 55: Nutritional Supplements ........................................................................................................ 299
b b b
Chapter 56: Dermatologic Drugs ................................................................................................................ 304
b b b
Chapter 57: Ophthalmic Drugs ................................................................................................................... 310
b b b
Chapter 58: Otic Drugs ............................................................................................................................... 315
b b b
, Chapter 01: The Nursing Process and Drug Therapy b b b b b b b
MULTIPLE CHOICE b
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
b b b b b b b b b b b b b b b b b b
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
b b b b b b b b b b b b b b
diagnosis?
b
a. Anxiety
b. Anxiety related to new drug therapy b b b b b
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
b b b b b b b b b b b
such as “I’m upset about having to test my blood sugars.”
b b b b b b b b b b b
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
b b b b b b b b b b b b
upset about having to test my blood sugars.”
b b b b b b b b
ANS: D b
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
b b b b b b b b b b b b b
to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drug
b b b b b b b b b b b b b b
therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
b b b b b b b b b b b b b
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
b b b b b b b b b b b b b b
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
b b b b b b b b b b b b b b b
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 7 b b b b b
TOP: NURSING PROCESS: Nursing Diagnosis
b b b b b
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
b b b b b b b b b
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
b b b b b b b b b b b b b b b b
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
b b b b b b b b b b b b b b b b b
represent?
b
a. “Right time” b
b. “Right dose” b
c. “Right route” b
d. “Right medication” b
ANS: A b
“Right time” is correct because the medication was given more than 30 minutes after the scheduled
b b b b b b b b b b b b b b b
dose was due. “Dose” is incorrect because the dose is not related to the time the medication
b b b b b b b b b b b b b b b b b
administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
b b b b b b b b b b b b b b
incorrect because the medication ordered will not change.
b b b b b b b b
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 11 b b b b b
TOP: NURSING PROCESS: Implementation
b b b b
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
b b b b b b b b b b
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
b b b b b b b b b b b b b b b b
and documenting the patient’s therapeutic response to the medication. Which phase of the
b b b b b b b b b b b b b
nursing process do these actions illustrate?
b b b b b b
a. Nursing diagnosis b
b
,TEST BANK FOR
b b
Pharmacology and the Nursing Process 8th Edition
b b b b b b
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
b b b b b b b b
Contents
Chapter 01: The Nursing Process and Drug Therapy....................................................................................... 4
b b b b b b b
Chapter 02: Pharmacologic Principles ............................................................................................................ 8
b b b
Chapter 03: Lifespan Considerations............................................................................................................ 14
b b b
Chapter 04: Cultural, Legal, and Ethical Considerations ............................................................................... 20
b b b b b b
Chapter 05: Medication Errors: Preventing and Responding........................................................................ 26
b b b b b b
Chapter 06: Patient Education and Drug Therapy ........................................................................................ 29
b b b b b b
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ................................................ 34
b b b b b b b b
Chapter 08: Gene Therapy and Pharmacogenomics .................................................................................... 38
b b b b b
Chapter 09: Photo Atlas of Drug Administration .......................................................................................... 41
b b b b b b
Chapter 10: Analgesic Drugs......................................................................................................................... 50
b b b
Chapter 11: General and Local Anesthetics.................................................................................................. 57
b b b b b
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................... 61
b b b b b b b b
Chapter 13: Central Nervous System Stimulants and Related Drugs ............................................................ 66
b b b b b b b b
Chapter 14: Antiepileptic Drugs ................................................................................................................... 70
b b b
Chapter 15: Antiparkinson Drugs ................................................................................................................. 76
b b b
Chapter 16: Psychotherapeutic Drugs .......................................................................................................... 81
b b b
Chapter 17: Substance Abuse ...................................................................................................................... 88
b b b
Chapter 18: Adrenergic Drugs ...................................................................................................................... 93
b b b
Chapter 19: Adrenergic-Blocking Drugs ....................................................................................................... 98
b b b
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
b b b
Chapter 21: Cholinergic-Blocking Drugs ..................................................................................................... 108
b b b
Chapter 22: Antihypertensive Drugs .......................................................................................................... 113
b b b
Chapter 23: Antianginal Drugs ................................................................................................................... 119
b b b
Chapter 24: Heart Failure Drugs ................................................................................................................. 125
b b b b
Chapter 25: Antidysrhythmic Drugs ........................................................................................................... 131
b b b
Chapter 26: Coagulation Modifier Drugs .................................................................................................... 137
b b b b
Chapter 27: Antilipemic Drugs ................................................................................................................... 143
b b b
,Chapter 28: Diuretic Drugs ......................................................................................................................... 148
b b b
Chapter 29: Fluids and Electrolytes ............................................................................................................ 154
b b b b
Chapter 30: Pituitary Drugs ........................................................................................................................ 160
b b b
Chapter 31: Thyroid and Antithyroid Drugs................................................................................................ 163
b b b b b
Chapter 32: Antidiabetic Drugs .................................................................................................................. 168
b b b
Chapter 33: Adrenal Drugs ......................................................................................................................... 177
b b b
Chapter 34: Women’s Health Drugs ........................................................................................................... 181
b b b b
Chapter 35: Men’s Health Drugs ................................................................................................................ 188
b b b b
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ............................................ 193
b b b b b b
Chapter 37: Respiratory Drugs ................................................................................................................... 198
b b b
Chapter 38: Antibiotics Part 1..................................................................................................................... 204
b b b b
Chapter 39: Antibiotics Part 2..................................................................................................................... 211
b b b b
Chapter 40: Antiviral Drugs ........................................................................................................................ 216
b b b
Chapter 41: Antitubercular Drugs .............................................................................................................. 221
b b b
Chapter 42: Antifungal Drugs ..................................................................................................................... 226
b b b
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................. 231
b b b b b b
Chapter 44: Anti-inflammatory and Antigout Drugs................................................................................... 236
b b b b b
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs.......................... 242
b b b b b b b b b b b
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ............. 248
b b b b b b b b b b b
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ........................................................ 253
b b b b b b
Chapter 48: Immunosuppressant Drugs .................................................................................................... 258
b b b
Chapter 49: Immunizing Drugs ................................................................................................................... 263
b b b
Chapter 50: Acid-Controlling Drugs............................................................................................................ 268
b b b
Chapter 51: Bowel Disorder Drugs ............................................................................................................. 274
b b b b
Chapter 52: Antiemetic and Antinausea Drugs .......................................................................................... 281
b b b b b
Chapter 53: Vitamins and Minerals ............................................................................................................ 286
b b b b
Chapter 54: Anemia Drugs ......................................................................................................................... 292
b b b
Chapter 55: Nutritional Supplements ........................................................................................................ 299
b b b
Chapter 56: Dermatologic Drugs ................................................................................................................ 304
b b b
Chapter 57: Ophthalmic Drugs ................................................................................................................... 310
b b b
Chapter 58: Otic Drugs ............................................................................................................................... 315
b b b
, Chapter 01: The Nursing Process and Drug Therapy b b b b b b b
MULTIPLE CHOICE b
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
b b b b b b b b b b b b b b b b b b
diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
b b b b b b b b b b b b b b
diagnosis?
b
a. Anxiety
b. Anxiety related to new drug therapy b b b b b
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements
b b b b b b b b b b b
such as “I’m upset about having to test my blood sugars.”
b b b b b b b b b b b
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
b b b b b b b b b b b b
upset about having to test my blood sugars.”
b b b b b b b b
ANS: D b
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
b b b b b b b b b b b b b
to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drug
b b b b b b b b b b b b b b
therapy” is missing the “as evidenced by” portion of defining characteristics. The statement
b b b b b b b b b b b b b
beginning “Anxiety related to anxious feelings” is incorrect because the “related to” section is
b b b b b b b b b b b b b b
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
b b b b b b b b b b b b b b b
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 7 b b b b b
TOP: NURSING PROCESS: Nursing Diagnosis
b b b b b
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
b b b b b b b b b
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and
b b b b b b b b b b b b b b b b
gave the medication 2 hours after the scheduled dose was due. What type of problem does this
b b b b b b b b b b b b b b b b b
represent?
b
a. “Right time” b
b. “Right dose” b
c. “Right route” b
d. “Right medication” b
ANS: A b
“Right time” is correct because the medication was given more than 30 minutes after the scheduled
b b b b b b b b b b b b b b b
dose was due. “Dose” is incorrect because the dose is not related to the time the medication
b b b b b b b b b b b b b b b b b
administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
b b b b b b b b b b b b b b
incorrect because the medication ordered will not change.
b b b b b b b b
DIF: COGNITIVE LEVEL: Applying (Application) REF: p. 11 b b b b b
TOP: NURSING PROCESS: Implementation
b b b b
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
b b b b b b b b b b
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
b b b b b b b b b b b b b b b b
and documenting the patient’s therapeutic response to the medication. Which phase of the
b b b b b b b b b b b b b
nursing process do these actions illustrate?
b b b b b b
a. Nursing diagnosis b
